Pharmacovigilance is critical for biologics due to their potential for rare but serious adverse effects. Continuous monitoring of adverse events post-approval helps in identifying new safety signals and ensuring ongoing patient safety. This process involves collecting and analyzing data from various sources, including healthcare providers and patients.
